查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565658

傳染病分子診斷市場，按測試類型、按應用、按產品和服務、按技術、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Infectious Diseases Molecular Diagnostics Market, By Test Type, By Application, By Products & Services, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年傳染病分子診斷市場規模為370.9432億美元，2024年至2032年複合年成長率為4.30%。

傳染病分子診斷市場-市場動態

傳染病發生率的上升推動了對傳染病分子診斷市場的需求

包括病毒、細菌、真菌和寄生蟲感染在內的傳染病患者病率不斷上升，大大增加了對有效診斷解決方案的需求。傳染病日益成為全球健康問題，特別是隨著新病原體的出現和先前控制的疾病的重新出現。根據美國國立衛生研究院 (NIH) 的數據，傳染病仍然是全球發病和死亡的主要原因之一，全球每年有超過 5,200 萬人 (33%) 死亡。世界上一半的人口仍面臨新發和再發傳染病的風險。最近的數據顯示，全球估計有 1,400 萬 5 歲以下兒童死亡，其中 70% 是由疫苗可預防的疾病造成的，其中 99% 發生在發展中國家。這推動了對先進分子診斷的需求，這種診斷可以在分子層面上快速、準確且靈敏地檢測病原體。儘早識別傳染源的能力可以及時干預，幫助疾病管理，降低傳播率並改善患者的治療結果。因此，傳染病負擔的增加是推動傳染病分子診斷市場成長的關鍵因素。

傳染病分子診斷市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.30% 左右的複合年成長率成長

根據測試類型細分，預計基於實驗室的測試將在 2023 年顯示最大的市場佔有率

按應用細分，2023年病毒感染為主導類型

根據產品和服務細分，試劑和試劑盒是 2023 年的主導類型

從技術細分來看，聚合酶鍊式反應（PCR）是2023年的主導類型

根據最終用戶細分，醫院和診斷實驗室是 2023 年的主導類型

按地區分類，亞太地區是 2023 年領先的收入來源

傳染病分子診斷市場-細分分析：

全球傳染病分子診斷市場根據測試類型、應用、產品和服務、技術、最終用戶和地區進行細分。

市場根據技術分為七類：聚合酶鍊式反應 (PCR)、等溫核酸擴增技術 (INAAT)、次世代定序 (NGS)、DNA 微陣列、基於雜交的檢測、CRISPR 診斷和其他 (Sanger)定序、多重PCR 等）。 PCR 可以高度準確地檢測來自病原體的少量 DNA 或 RNA，使其成為診斷傳染病的理想選擇。這種精確度可以實現早期、準確的檢測，這對於疾病管理和控制至關重要。即時 PCR (qPCR) 和數位 PCR (dPCR) 的發展增強了 PCR 的準確性、靈敏度和定量能力，使其成為傳染病檢測中更具吸引力的選擇。

根據最終用途產業，市場分為五類：醫院和診斷實驗室、研究所、照護端測試設施、學術和醫療機構以及其他。醫院收治了大量的傳染病患者，需要先進的診斷工具來確保準確、及時的診斷。這推動了對分子診斷的需求，這對於在分子層面上以高特異性和敏感性檢測病原體至關重要。高患者數量、技術進步、融入患者護理、研究參與和監管要求等因素相結合，使得醫院在傳染病分子診斷市場中佔據了巨大的市場佔有率。

傳染病分子診斷市場-地理洞察

在傳染病流行率不斷上升、醫療基礎設施進步以及人們對早期疾病檢測意識不斷提高等因素的推動下，亞太地區傳染病分子診斷市場正在顯著成長。中國、印度、日本和韓國等國家是這一成長的主要貢獻者，對快速診斷測試的需求激增，特別是在 COVID-19 等流行病爆發後。此外，政府的支持性政策、醫療保健創新資金的增加以及對精準醫療的日益關注正在促進分子診斷在整個地區的採用。

傳染病分子診斷市場-競爭格局：

傳染病分子診斷市場的特點是競爭激烈，全球主要參與者包括羅氏診斷公司、雅培實驗室、賽默飛世爾科技公司、丹納赫公司和豪洛捷公司。產品組合在市場上佔據主導地位。例如，羅氏公司以其高度先進的聚合酶鍊式反應 (PCR) 技術處於領先地位。 Abbott 和 Thermo Fisher 在快速檢測和新一代定序 (NGS) 領域的產品也佔有重要的市場佔有率。生物梅里埃、Qiagen 和 Cepheid（丹納赫子公司）等中型企業也很突出，為傳染病提供專門的分子診斷解決方案。新創公司和區域性公司正在利基領域進行創新，透過具有成本效益的快速診斷工具增加了競爭壓力。隨著公司旨在加強其產品組合和全球影響力，合作和策略收購是主要趨勢。

最新進展：

2024年1月，Seegene宣布與微軟合作，實現「沒有疾病的世界」。這項策略合作開啟了分子診斷領域的新篇章，旨在建立一個沒有所有疾病和未來流行病的世界。

2020 年 2 月，Cepheid 和 Sherlock Biosciences 就利用 CRISPR 技術進行傳染病和腫瘤學的 New GeneXpert 測試建立了合作。此次合作將重點放在傳染病和腫瘤學的分子診斷測試，首先是專注於檢測冠狀病毒（SARS-CoV-2）的概念驗證計畫。

目錄

第1章：傳染病分子診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按測試類型分類的傳染病分子診斷市場片段
    • 傳染病分子診斷市場片段（依應用）
    • 按產品和服務分類的傳染病分子診斷市場片段
    • 傳染病分子診斷市場技術片段
    • 最終用戶的傳染病分子診斷市場片段
    • 按國家/地區分類的傳染病分子診斷市場片段
    • 按地區分類的傳染病分子診斷市場片段
  • 競爭洞察

第 3 章：傳染病分子診斷主要市場趨勢

  • 傳染病分子診斷市場促進因素
    • 市場促進因素的影響分析
  • 傳染病分子診斷市場限制
    • 市場限制影響分析
  • 傳染病分子診斷市場機會
  • 傳染病分子診斷市場未來趨勢

第 4 章：傳染病分子診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：傳染病分子診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：傳染病分子診斷市場格局

  • 2023 年傳染病分子診斷市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：傳染病分子診斷市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 實驗室測試
    • 即時分子診斷
    • 自檢套件

第 8 章：傳染病分子診斷市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 病毒感染
    • 細菌感染
    • 寄生蟲感染
    • 黴菌感染
    • 其他（人畜共通感染等）

第 9 章：傳染病分子診斷市場 - 按產品和服務

  • 概述
    • 按產品和服務分類的細分市場佔有率分析
    • 試劑和試劑盒
    • 儀器儀表
    • 軟體與服務

第 10 章：傳染病分子診斷市場 - 依技術分類

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 聚合酶鍊式反應 (PCR)
      • 即時螢光定量PCR (qPCR)
      • 逆轉錄聚合酶連鎖反應 (RT-PCR)
      • 其他
    • 等溫核酸擴增技術（INAAT）
    • 新一代定序 (NGS)
    • DNA微陣列
    • 基於雜交的測定
    • CRISPR 診斷
    • 其他（桑格定序、多重 PCR 等）

第 11 章：傳染病分子診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診斷實驗室
    • 研究所
    • 即時偵測設施
    • 學術及醫療機構
    • 其他

第 12 章：傳染病分子診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美傳染病分子診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按產品和服務）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲傳染病分子診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按產品和服務）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區傳染病分子診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 按測試類型分類的亞太市場規模和預測
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按產品和服務）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲傳染病分子診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按測試類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按產品和服務）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲傳染病分子診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按產品和服務）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第13章：主要供應商分析-傳染病分子診斷產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Roche Diagnostics
    • BD (Becton, Dickinson and Company)
    • Thermo Fisher Scientific
    • Cepheid
    • QIAGEN
    • BioMerieux
    • GenMark Diagnostics
    • Luminex Corporation
    • MicroGen Diagnostics
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3817

REPORT HIGHLIGHT

Infectious Diseases Molecular Diagnostics Market size was valued at USD 37,094.32 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.

The Infectious Diseases Molecular Diagnostics market is a rapidly expanding sector driven by the increasing prevalence of infectious diseases, technological advancements in molecular diagnostics, and the need for precise, fast, and reliable diagnostic tools. Molecular diagnostics offer high sensitivity and specificity, allowing for early detection and monitoring of diseases caused by bacteria, viruses, fungi, and parasites. Key market drivers include the rise in healthcare spending, the growing burden of infectious diseases like COVID-19, HIV, and tuberculosis, and the demand for point-of-care testing solutions. As a result, companies are focusing on developing innovative diagnostic platforms, leading to enhanced market growth across regions, with North America and Europe being major contributors.

Infectious Diseases Molecular Diagnostics Market- Market Dynamics

Rising Prevalence of Infectious Diseases Drives the Need for the Infectious Diseases Molecular Diagnostics Market

The rising prevalence of infectious diseases, including viral, bacterial, fungal, and parasitic infections, has significantly increased the demand for effective diagnostic solutions. Infectious diseases pose a growing global health concern, particularly with the emergence of new pathogens and the re-emergence of previously controlled diseases. According to the National Institute of Health (NIH), Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Half of the world's population remains at risk of emerging and re-emerging infectious diseases. The recent figures indicate an estimated 14 million global deaths in children less than 5 years of age, 70% of which resulted from vaccine-preventable diseases and 99% reported in developing countries. This has driven the need for advanced molecular diagnostics, which provide rapid, accurate, and sensitive detection of pathogens at a molecular level. The ability to identify infectious agents early on allows for timely intervention, aiding in disease management, reducing transmission rates, and improving patient outcomes. Consequently, the increasing burden of infectious diseases is a key factor propelling the growth of the infectious diseases molecular diagnostics market.

Infectious Diseases Molecular Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)

Based on test type segmentation, Laboratory-based Tests were predicted to show maximum market share in the year 2023

Based on application segmentation, Viral Infections was the leading type in 2023

Based on Product & Service segmentation, Reagents & Kits was the leading type in 2023

Based on technology segmentation, Polymerase Chain Reaction (PCR) was the leading type in 2023

Based on end-user segmentation, Hospitals & Diagnostic Laboratories was the leading type in 2023

On the basis of region, Asia Pacific was the leading revenue generator in 2023

Infectious Diseases Molecular Diagnostics Market- Segmentation Analysis:

The Global Infectious Diseases Molecular Diagnostics Market is segmented on the basis of Test Type, Application, Product & Services, Technology, End User, and Region.

The market is divided into seven categories based on technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), DNA Microarray, Hybridization-based Assays, CRISPR Diagnostics, and Others (Sanger Sequencing, Multiplex PCR, etc.). PCR is highly accurate in detecting even small amounts of DNA or RNA from pathogens, making it ideal for diagnosing infectious diseases. This precision leads to early and accurate detection, essential for disease management and control. The development of real-time PCR (qPCR) and digital PCR (dPCR) has enhanced PCR's accuracy, sensitivity, and quantification capabilities, making it an even more attractive option in infectious disease testing.

The market is divided into five categories based on end use industry: Hospitals & Diagnostic Laboratories, Research Institutes, Point-of-Care Testing Facilities, Academic and Medical Institutions, and Others. Hospitals experience a high volume of patients with infectious diseases, necessitating advanced diagnostic tools to ensure accurate and timely diagnosis. This drives the demand for molecular diagnostics, which are crucial for detecting pathogens at a molecular level with high specificity and sensitivity. The combination of high patient volumes, technological advancements, integration into patient care, research involvement, and regulatory requirements contributes to the substantial market share held by hospitals in the Infectious Diseases Molecular Diagnostics market.

Infectious Diseases Molecular Diagnostics Market- Geographical Insights

The Asia-Pacific region is witnessing significant growth in the Infectious Diseases Molecular Diagnostics market, driven by factors such as the increasing prevalence of infectious diseases, advancements in healthcare infrastructure, and rising awareness about early disease detection. Countries like China, India, Japan, and South Korea are key contributors to this growth, with a surge in demand for rapid diagnostic tests, particularly in the wake of pandemics such as COVID-19. Additionally, supportive government policies, increased funding for healthcare innovation, and a growing focus on precision medicine are fostering the adoption of molecular diagnostics across the region.

Infectious Diseases Molecular Diagnostics Market- Competitive Landscape:

The Infectious Diseases Molecular Diagnostics market is characterized by a competitive landscape featuring key global players, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Hologic Inc. These companies dominate the market due to their strong portfolios of molecular diagnostic platforms, extensive distribution networks, and focus on research and development. Roche, for instance, leads with its highly advanced polymerase chain reaction (PCR) technology. Abbott and Thermo Fisher also hold significant market shares with their offerings in rapid testing and next-generation sequencing (NGS). Mid-sized players like bioMerieux, Qiagen, and Cepheid (a subsidiary of Danaher) are also prominent, providing specialized molecular diagnostic solutions for infectious diseases. Start-ups and regional companies are innovating in niche areas, adding competitive pressure with cost-effective and rapid diagnostic tools. Collaboration and strategic acquisitions are key trends as companies aim to strengthen their portfolios and global reach.

Recent Developments:

In Jan 2024, Seegene Announced the collaboration with Microsoft to Realize 'a World Free from All Diseases'. This strategic collaboration opens a new chapter in the field of molecular diagnostics that aspires to a world free from all diseases and future pandemics.

In February 2020, Cepheid and Sherlock Biosciences established collaboration on New GeneXpert tests for infectious diseases and oncology leveraging CRISPR Technology. The collaboration will focus on molecular diagnostic tests for infectious diseases and oncology, beginning with a proof-of-concept project focused on the detection of coronavirus (SARS-CoV-2).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • BD (Becton, Dickinson and Company)
  • Thermo Fisher Scientific
  • Cepheid
  • QIAGEN
  • BioMerieux
  • GenMark Diagnostics
  • Luminex Corporation
  • MicroGen Diagnostics
  • Others

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Laboratory-based Tests
  • Point-of-Care Molecular Diagnostics
  • Self-testing Kits

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Viral Infections
  • Bacterial Infections
  • Parasitic Infections
  • Fungal Infections
  • Others (Zoonotic Infections, etc.)

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICES - MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Instruments
  • Software & Services

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Real-time PCR (qPCR)
  • Reverse transcription PCR (RT-PCR)
  • Others
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Hybridization-based Assays
  • CRISPR Diagnostics
  • Others (Sanger Sequencing, Multiplex PCR, etc.)

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Point-of-Care Testing Facilities
  • Academic and Medical Institutions
  • Others

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Diseases Molecular Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Diseases Molecular Diagnostics Market Snippet by Test Type
    • 2.1.2. Infectious Diseases Molecular Diagnostics Market Snippet by Application
    • 2.1.3. Infectious Diseases Molecular Diagnostics Market Snippet by Products & Services
    • 2.1.4. Infectious Diseases Molecular Diagnostics Market Snippet by Technology
    • 2.1.5. Infectious Diseases Molecular Diagnostics Market Snippet by End User
    • 2.1.6. Infectious Diseases Molecular Diagnostics Market Snippet by Country
    • 2.1.7. Infectious Diseases Molecular Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Diseases Molecular Diagnostics Key Market Trends

  • 3.1. Infectious Diseases Molecular Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Diseases Molecular Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Diseases Molecular Diagnostics Market Opportunities
  • 3.4. Infectious Diseases Molecular Diagnostics Market Future Trends

4. Infectious Diseases Molecular Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Diseases Molecular Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Diseases Molecular Diagnostics Market Landscape

  • 6.1. Infectious Diseases Molecular Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Diseases Molecular Diagnostics Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Laboratory-based Tests
    • 7.1.3. Point-of-Care Molecular Diagnostics
    • 7.1.4. Self-testing Kits

8. Infectious Diseases Molecular Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Viral Infections
    • 8.1.3. Bacterial Infections
    • 8.1.4. Parasitic Infections
    • 8.1.5. Fungal Infections
    • 8.1.6. Others (Zoonotic Infections, etc.)

9. Infectious Diseases Molecular Diagnostics Market - By Products & Services

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Products & Services, 2023 & 2032 (%)
    • 9.1.2. Reagents & Kits
    • 9.1.3. Instruments
    • 9.1.4. Software & Services

10. Infectious Diseases Molecular Diagnostics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Polymerase Chain Reaction (PCR)
      • 10.1.2.1. Real-time PCR (qPCR)
      • 10.1.2.2. Reverse transcription PCR (RT-PCR)
      • 10.1.2.3. Others
    • 10.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 10.1.4. Next-Generation Sequencing (NGS)
    • 10.1.5. DNA Microarray
    • 10.1.6. Hybridization-based Assays
    • 10.1.7. CRISPR Diagnostics
    • 10.1.8. Others (Sanger Sequencing, Multiplex PCR, etc.)

11. Infectious Diseases Molecular Diagnostics Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals & Diagnostic Laboratories
    • 11.1.3. Research Institutes
    • 11.1.4. Point-of-Care Testing Facilities
    • 11.1.5. Academic and Medical Institutions
    • 11.1.6. Others

12. Infectious Diseases Molecular Diagnostics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Infectious Diseases Molecular Diagnostics Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Roche Diagnostics
    • 13.2.3. BD (Becton, Dickinson and Company)
    • 13.2.4. Thermo Fisher Scientific
    • 13.2.5. Cepheid
    • 13.2.6. QIAGEN
    • 13.2.7. BioMerieux
    • 13.2.8. GenMark Diagnostics
    • 13.2.9. Luminex Corporation
    • 13.2.10. MicroGen Diagnostics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us